ZAP-70 in CLL: Towards standardization of a biomarker for patient management: History of clinical cytometry special issue

Cytometry Part B - Clinical Cytometry

Volumn 70, Issue 4, 2006, Pages 197-200

  Marti, Gerald ^a,d   Orfao, Alberto ^b   Goolsby, Chuck ^c  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c NORTHWESTERN UNIVERSITY   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

CLL; Flow cytometry; ZAP 70

Indexed keywords

BIOLOGICAL MARKER; PROTEIN KINASE ZAP 70;

CHRONIC LYMPHATIC LEUKEMIA; CYTOGENETICS; EDITORIAL; FLOW CYTOMETRY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

FLOW CYTOMETRY; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 33748515699     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20137     Document Type: Editorial

References (24)

1. Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X, Yang L, Pickeral OK, Rassenti LZ, Powell J, Botstein D, Byrd JC, Grever MR, Cheson BD, Chiorazzi N, Wilson WH, Kipps TJ, Brown PO, Staudt LM. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001;194:1639-1647.
2. Wiestner A, Rosenwald A, Barry T, Wright G, Davis RE, Henrickson SE, Zhao H, Ibbotson, Orchard JA, Davis Z, Stetler-Stevenson M, Raffeld M, Marti GE, Wilson WH, Hamblin TJ, Oscier DG, Staudt LM. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome and distinct gene expression profile. Blood 2003;101:4944-4951.
3. Crespo M. ZAP-70 expression as a surrogate for immunoglobulin-variable- region mutations in chronic lymphocytic leukemia. N Engl J Med 2003;348:1764-1775.
4. Rai KR, Chiorazzi N. Determining the clinical course and outcome in chronic lymphocytic leukemia. N Engl J Med 2003;348:1797, 1798.
5. Orchard JA, Ibbotson RE, Davis Z, Wiestner A, Rosenwald A, Thomas PW, Hamblin TJ, Staudt LM, Oscier DG. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 2004;363:105-111.
6. Rassenti LZ. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004;351:893-901.
7. Kay S, Herishanu Y, Pick M, Rogowski O, Baron S, Naparstek E, Polliack A, Deutsch VR. Quantitative flow cytometry of ZAP-70 levels in chronic lymphocytic leukemia using molecules of equivalent soluble fluorochrome. Cytometry Part B Clin Cytometry 2006;70B:218-226.
8. Shults KE, Miller DT, Davis BH, Flye, Hobbs L, Stelzer GT. A standardized ZAP-70 assay-lessons learned in the trenches. Cytometry Part B Clin Cytometry 2006;70B:276-283.
9. Shankey V, Scibellil P, Cobb J, Smith CM, Mills R, Beranl E, van der Heiden M, Popma J, Forman M, Keeney M. An optimized whole blood method for flow cytometric measurement of ZAP-70 protein expression in chronic lymphocytic leukemia. Cytometry Part B Clin Cytometry 2006;70B:259-269.
10. Shenkin M, Maiese R. Use of a blocking antibody method for the flow cytometric measurement of zap-70 in B-CLL. Cytometry Part B Clin Cytometry 2006;70B:251-258.
11. Bojarska-Junak A, Giannopoulos K, Kowal M, Dmoszynska A, Rolinski J. Comparison of methods for determining ζ-chain associated protein-70 (ZAP-70) expression in patients with B-cell chronic lymphocytic leukemia (B-CLL). Cytometry Part B Clin Cytometry 2006;70B:293-300.
12. Bakke AC, Purtzer Z, Leis J, Huang J. A robust ratio metric method for analysis of Zap-70 expression in chronic lymphocytic leukemia (CLL). Cytometry Part B Clin Cytometry 2006;70B:227-234.
13. Best OG, Ibbotson RE, Parker AE, Davis ZA, Orchard JA, Oscier DG. ZAP-70 by flow cytometry: A comparison of different antibodies, anticoagulants and methods of analysis. Cytometry Part B Clin Cytometry 2006;70B:235-241.
14. Van Bockstaele F, Janssens A, Piette A, Callewaert F, Pede V, Offner F, Verhasselt V, Philippe J. Kolmogorov-Smirnov statistical test for analysis of ZAP-70 expression in B-CLL, compared with quantitative PCR and IgVH mutation status. Cytometry Part B Clin Cytometry 2006;70B:301-307.
15. Sheikholeslami MR, Jilani I, Keating M, Uyejie J, Chen K, Kantarjian H, O'Brien S, Giles F, Albitar M. Variations in the detection of ZAP-70 in CLL: Comparison with IgVH mutation analysis. Cytometry Part B Clin Cytometry 2006;70B:270-275.
16. Zucchetto A, Bomben R, Dal Bo M, Nanni P, Bulian P, Rossi FM, Del Principe MI, Santini S, Del Poeta G, Degan M, Gattei V. ZAP-70 expression in B-cell chronic lymphocytic leukemia: Evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgVH mutations. Cytometry Part B Clin Cytometry 2006;70B:284-292.
17. Wilhelm C, Neubauer A, Brendel C. Discordant results of flow cytometric ZAP-70 expression status in B-CLL samples if different strategies are applied. Cytometry Part B Clin Cytometry 2006;70B:242-250.
18. Letescu R, Rawstron A, Ghia P, et al. on behalf of the European Research Initiative in CLL (ERIC) and the Leukemianet. Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia (CLL): A multicentric international harmonization process. Cytometry Part B Clin Cytometry 2006;70B:308-313.
19. Rassenti LZ, Kipps TJ. Clinical utility of assessing for ZAP-70 and CD38 in chronic lymphocytic leukemia. Cytometry Part B Clin Cytometry 2006;70B:209-213.
20. Bosch F, Muntañola A, Giné E, Carrió A, Villamor N, Moreno C, Crespo M, Montserrat E. Clinical implications of ZAP-70 expression in chronic lymphocytic leukemia. Cytometry Part B Clin Cytometry 2006;70B:214-217.
21. Wiestner A. Flow cytometry for ZAP-70: New colors for chronic lymphocytic leukemia. Cytometry Part B Clin Cytometry 2006;70B:201-203.
22. Sheridan R, Mounajjed T, Ehrmann DE, Hurtubise PE, Schrager JA. Comparison of bone marrow and peripheral blood ZAP-70 status examined by flow cytometric immunophenotyping in patients with chronic lymphocytic leukemia. Cytometry Part B Clin Cytometry 2006;70B:319-320.
23. Davis BH, Schwartz S. ZAP-70 expression is low in normal precusor B Cells or hematogones. Cytometry Part B Clin Cytometry 2006;70B:314-318.
24. Bené MC. What is ZAP-70? Cytometry Part B Clin Cytometry 2006;70B:204-208.